Piperazine derivatives used as CAV2.2 calcium channel modulators
US8530478B2 · kind B2 · utility
0Cited by
6References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 15, 2009 |
| Grant date | Sep 10, 2013 |
| Priority date | — |
| Expiry date | Feb 10, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel piperazine derivatives (I); to processes for their preparation; to pharmaceutical compositions containing the derivatives; and to the use of the derivatives in therapy to treat diseases for which blocking the Cav2.2 calcium channels is beneficial.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.